• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center
 

Research Programs

Clinical-based Research

Breast Cancer

Clinical Trials

Clinical Trials

Representative Clinical Trials

  • Randomized Phase II trial of low-dose continuous chemotherapy (cyclophosphamide and methotrexate) with and without bevacizumab (Harold Burstein, MD, PhD, DFCI, Principal Investigator).
  • Neoadjuvant chemotherapy in palpable breast cancer: evaluation of physiologic, radiologic, and molecular markers in predicting response (Alphonse Taghian, MD, PhD, MGH, Principal Investigator).